神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本)
Mini Samples ELISA Kit for Neuropeptide Y (NPY)
NP-Y; PYY4; CPON; Pro-neuropeptide Y; Neuropeptide tyrosine; C-flanking peptide of NPY
- 編號MEA879Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法競爭抑制
- 反應時長3h
- 檢測范圍24.69-2,000pg/mL
- 靈敏度最小可檢測劑量小于等于9.59pg/mL.
- 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 3175 ¥ 4536 ¥ 20412 ¥ 38556 ¥ 317520
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應。
由于受到技術及樣本來源的限制,不可能完成對所有相關或相似物質(zhì)交叉反應檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應。
回收率
分別于定值血清及血漿樣本中加入一定量的神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本)(加標樣品),重復測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 99-105 | 102 |
EDTA plasma(n=5) | 92-105 | 97 |
heparin plasma(n=5) | 91-105 | 97 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 90-103% | 82-105% | 78-89% | 85-103% |
EDTA plasma(n=5) | 78-91% | 88-99% | 82-99% | 84-94% |
heparin plasma(n=5) | 92-99% | 90-102% | 92-101% | 78-93% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標準品、試劑及樣本的準備;
2. 加樣(標準品及樣本)25µL后,立即加入檢測溶液A25µL,
37°C孵育1小時;
3. 甩干,洗板3次;
4. 加檢測溶液B50µL,37°C孵育30分鐘;
5. 洗板5次;
6. 加TMB底物50µL,37°C孵育10-20分鐘;
7. 加終止液25µL,立即450nm讀數(shù)。
實驗原理
本試劑盒應用競爭抑制酶聯(lián)免疫分析法測定標本中待測物質(zhì)水平。將神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本)單克隆抗體包被微孔板,制成固相載體,往包被抗體的微孔中同時加入生物素標記的抗原和待測抗原(標準品或樣本),待測抗原與生物素標記抗原對特異性抗體進行競爭結合。溫育后經(jīng)洗滌去掉未結合物,然后加入HRP標記的親和素,經(jīng)過溫育和徹底洗滌后加入底物TMB顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍色,并在酸的作用下轉(zhuǎn)化成最終的黃色。待測標本濃度越高,標記抗原和抗體的結合就越受到抑制,顯色愈淺。顯色的深淺與酶量呈正相關,而與樣品中待測物質(zhì)含量呈負相關。用酶標儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
增值服務
相關產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPA879Hu01 | 神經(jīng)肽Y(NPY)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA879Hu22 | 神經(jīng)肽Y(NPY)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
CPA879Hu21 | 神經(jīng)肽Y(NPY)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA879Hu08 | 神經(jīng)肽Y(NPY)多克隆抗體 | WB; IHC; ICC; IP. |
PAA879Hu01 | 神經(jīng)肽Y(NPY)多克隆抗體 | WB; IHC; ICC; IP. |
LAA879Hu71 | 神經(jīng)肽Y(NPY)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAA879Hu22 | 神經(jīng)肽Y(NPY)單克隆抗體 | WB; IHC; ICC; IP. |
MEA879Hu | 神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEA879Hu | 神經(jīng)肽Y(NPY)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA879Hu | 神經(jīng)肽Y(NPY)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA879Hu11 | 神經(jīng)肽Y(NPY)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Hemodialysis International | Is there any interaction of resistin and adiponectin levels with protein‐energy wasting among patients with chronic kidney disease [Onlinelibrary: hdi.12072] |
Journal of Pediatric Endocrinology and Metabolism | Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children [Degruyter: Source] |
Ren Fail. | The role of adipocytokines on depressive symptoms of patients with chronic kidney disease [Pubmed: 23879728] |
Coronary Artery Disease | The relationship of plasma neuropeptide Y levels with coronary collateral development. [Pubmed: 24077326] |
Coronary Artery Disease | The relationship of plasma neuropeptide Y levels with coronary collateral development [Lww:Source] |
Toxicology Letters | Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate [Pubmed:25623392] |
J Neurosurg Anesthesiol | High Plasma Levels of Neuropeptide Y Correlate With Good Clinical Outcome But are not Correlated to Cerebral Blood Flow or Vasospasm After Subarachnoid Hemorrhage [PubMed: 25955865] |
Journal of Diabetes Research | High Intensity Aerobic Exercise Training Improves Deficits of Cardiovascular Autonomic Function in a Rat Model of Type 1 Diabetes Mellitus with Moderate … [Pubmed:26885531] |
Archives of Gynecology and Obstetrics | Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate [pubmed:27604241] |
basic & clinical pharmacology & toxicology | Effects of Di-isononyl Phthalate on Neuropeptide Y Expression in Differentiating Human Neuronal Cells. [pubmed:27625336] |
Acta?Neurobiologiae Experimentalis | Aberrant changes of somatostatin and neuropeptide Y in brain of a genetic rat model for epilepsy: tremor rat [pubmed:27685769] |
Cardiovascular?research | Nur77 protects against adverse cardiac remodelling by limiting Neuropeptide Y signalling in the sympathoadrenal-cardiac axis [Pubmed:29850786] |
Journal of Periodontology | Salivary neuropeptides, stress, and periodontitis [Pubmed:28914594] |
Neuropeptides | Mechanisms of sustained long-term weight loss after RYGB: α-MSH is a key factor [Pubmed:29685637] |
Pharmacology | Melatonin Induces Osteoblastic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing in a Rat Model of Femoral Fracture via Neuropeptide Y?… [Pubmed: 30227410] |
Marmara Medical Journal | Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome [] |
Marmara Medical Journal | Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome. [] |
neurochemical research | Sevoflurane Induces Hippocampal Neuronal Apoptosis by Altering the Level of Neuropeptide Y in Neonatal Rats. [Pubmed: 32378074] |
Hum Psychopharmacol | Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double?\blind randomized??- [33245168] |
Arch Toxicol | Serotonin involvement in okadaic acid-induced diarrhoea in vivo [34148100] |